Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial.

@article{Heys2002NeoadjuvantDI,
  title={Neoadjuvant docetaxel in breast cancer: 3-year survival results from the Aberdeen trial.},
  author={Steven D. Heys and Andrew W. Hutcheon and Tarun Kumar Sarkar and Keith N. Ogston and Iain David Miller and Simon Payne and Ian. Smith and Leslie G. Walker and O. G. Eremin},
  journal={Clinical breast cancer},
  year={2002},
  volume={3 Suppl 2},
  pages={
          S69-74
        }
}
Over the past 30 years there has been an increased use of neoadjuvant (or primary) chemotherapy for treating patients with breast cancer. However, while it is clear that chemotherapy given in the adjuvant setting after surgery does prolong patients' overall and disease-free survival, the evidence that chemotherapy in the neoadjuvant setting also increases survival remains unproven. In the Aberdeen study, 162 patients with large and locally advanced breast cancer underwent 4 cycles of CVAP… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 76 CITATIONS, ESTIMATED 9% COVERAGE

Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.

  • The Surgical clinics of North America
  • 2007
VIEW 7 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Primary medical therapy and breast conservation treatment: the medical oncology perspective.

  • Gland surgery
  • 2018
VIEW 5 EXCERPTS
CITES METHODS & BACKGROUND
HIGHLY INFLUENCED

Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions.

  • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2009
VIEW 3 EXCERPTS
CITES RESULTS & BACKGROUND
HIGHLY INFLUENCED

Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancer.

  • Clinical cancer research : an official journal of the American Association for Cancer Research
  • 2004
VIEW 4 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Primary docetaxel chemotherapy in patients with breast cancer: impact on response and survival

  • Breast Cancer Research and Treatment
  • 2004
VIEW 4 EXCERPTS
CITES BACKGROUND, RESULTS & METHODS
HIGHLY INFLUENCED

Effects of adding taxane to anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer.

  • Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina
  • 2019
VIEW 3 EXCERPTS
CITES RESULTS & BACKGROUND

FILTER CITATIONS BY YEAR

2003
2019

CITATION STATISTICS

  • 5 Highly Influenced Citations

Similar Papers

Loading similar papers…